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Abstract 1 
A 13-year-old castrated male Maine coon cat with a 5-year history of atypical 2 
mycobacteriosis was euthanized and submitted for necropsy. The cat had been kept in 3 
clinical remission since diagnosis using a combination of the antimycobacterial drug 4 
clofazimine and additional multimodal antimicrobial therapy. Grossly, tissues were 5 
diffusely discolored red-brown to yellow. Histologically, the myocardial interstitum was 6 
expanded by numerous, often multinucleated cells, which were distended by uniformly 7 
shaped acicular cytoplasmic spaces. These cells were immunopositive for CD18 and 8 
immunonegative for desmin, suggesting a histiocytic rather than muscular origin. 9 
Macrophages in other tissues contained similar acicular spaces. Ultrastructurally, the 10 
spaces were surrounded by two lipid membranes, resembling an autophagosome. 11 
Based upon the clinical history and histologic, immunohistochemical, and ultrastructural 12 
data, we diagnosed clofazimine crystal storage. To our knowledge, this is the first report 13 
of clofazimine storage in a cat or within myocardial interstitial macrophages. 14 
Keywords: clofazimine, feline, heart, histiocyte, mycobacteria, Mycobacterium avium 15 
complex, mycobacteriosis 16 
 17 
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Clofazimine is a highly lipophilic phenazine dye with antimycobacterial and anti-1 
inflammatory properties. This drug is listed as an essential medicine by the World 2 
Health Organization and is most commonly utilized in humans for the treatment of 3 
leprosy and multi-drug resistant tuberculosis.27 In humans, adverse effects are generally 4 
self-limiting and include ichthyosis and pink discoloration of the skin in approximately 5 
94% of patients,20 less frequently, gastrointestinal pain20 and discoloration of the 6 
sclera,3 and rarely clofazimine storage enteropathy.24,26 Histologically, clofazimine 7 
storage enteropathy in humans is characterized by expansion of the gastrointestinal 8 
lamina propria by crystal-laden macrophages following prolonged treatment with high 9 
doses of clofazimine.24,26 This condition can lead to unnecessary laparotomy, either due 10 
to clinical signs suggestive of gastrointestinal obstruction24 or due to its radiologic 11 
similarity to neoplastic processes.25 In humans, storage of clofazimine crystals has also 12 
been reported in the macrophages of many tissues, including the lung,14,21,23 lymphoid 13 
organs, 19 liver,9 and eye.11   14 
In veterinary medicine, clofazimine is utilized in dogs and cats for the treatment 15 
of mycobacteriosis.4,16,22 Adverse effects are rarely reported but include hepatotoxicity, 16 
gastrointestinal signs, photosensitization, discoloration of the skin, and pitting corneal 17 
lesions.4,16 Histologically confirmed cases of clofazimine storage enteropathy associated 18 
with treatment for mycobacteriosis have not been reported in domestic animals. 19 
However, mice fed approximately 10mg/kg/day of clofazimine developed pink 20 
discoloration of the skin and hair and storage of clofazimine crystals within 21 
macrophages in the intestine, liver, spleen, and lungs.2 Interestingly for the current 22 
report, in this murine model, clofazimine did not accumulate within the heart.2 With 23 
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transmission electron microscopy, intrahistiocytic clofazimine crystals have been shown 1 
to be enveloped in a double lipid membrane, similar to those surrounding 2 
autophagosomes.1 3 
A 13-year-old castrated male Maine coon cat was submitted for necropsy. Eight 4 
years prior to necropsy, the cat developed self-limiting lymphadenomegaly, followed by 5 
immune-mediated retinal detachment, anemia, and thrombocytopenia. He was treated 6 
with multiple immunosuppressive medications over the next three years, culminating in 7 
hepatotoxicity due to cyclosporine overdosage 4.5 years prior to necropsy. Thereafter, 8 
immunosuppression was gradually tapered and discontinued, and the cat developed 9 
marked lymphadenomegaly and chemosis. Pyogranulomatous lymphadenitis with 10 
intracytoplasmic negative-staining bacilli was identified following cytologic evaluation of 11 
an enlarged superficial cervical lymph node. Mycobacterium avium was detected by 12 
mycobacterial culture and PCRperformed on 4 excised enlarged retropharyngeal lymph 13 
nodes. It was not possible to determine whether the cat’s mycobacteriosis reflected 14 
opportunistic infection secondary to chronic immunosuppression or if it had been the 15 
trigger for the cat’s original presentation with immune-mediated retinal detachment, 16 
anemia, and thrombocytopenia. 17 
A detailed description of the clinical course of this case and the treatments are 18 
presented in the Supplemental Materials. In short, for 8 years, the cat had been treated 19 
with various antimycobacterial agents and adjustments had been made as necessary to 20 
maintain clinical remission. These medications included enrofloxacin (32.5mg, q24h), 21 
rifampin (75mg, q24h), clarithromycin (62.5mg, q12h), amikacin (100mg, q24h), 22 
ethambutol (300mg, q12h), moxifloxacin (30mg, q24h), minocycline (50mg, q24h), 23 
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azithromycin (50mg, q24h), pradofloxacin (25mg, q24h), and clofazimine (50mg, q24h). 1 
Clofazimine therapy was initiated 4 years prior to necropsy but was discontinued 5 2 
months prior to euthanasia due to unavailability for use in veterinary medicine in the 3 
United States. Three months following initiation of treatment with clofazimine, the cat’s 4 
skin, fur, and sclera developed a pink hue; this discoloration waned after discontinuation 5 
of the medication. The cat was presented for euthanasia due to two weeks of weakness 6 
and rapidly progressive weight loss. At the time of death, the cat was being treated with 7 
azithromycin, pradofloxacin, and minocycline.  8 
Gross findings at necropsy included purple-brown to red discoloration of most 9 
tissues, including skeletal muscle, kidney, liver, and bone marrow; adipose tissue was 10 
discolored yellow to brown. Tissues stained cutting surfaces bright pink, discolored 11 
fixation solutions red-orange, and stained histological processing equipment bright pink 12 
to dark red. The heart was subjectively enlarged with thickened ventricular walls and 13 
weighed 33.8g, which was 0.78% of body weight  (University of Tennessee internal 14 
reference range 0.3-0.45%) and the liver weighed 240g, which was 5.5% of body weight 15 
(University of Tennessee internal reference range 3-3.5%). Cavitary effusions were not 16 
present. With the exception of the discoloration and multiple chronic renal infarcts, all 17 
organs were grossly unremarkable. 18 
Samples of all major tissues were collected and fixed in 10% buffered neutral 19 
formalin, processed routinely, and routinely stained with hematoxylin and eosin for light 20 
microscopic examination. For desmin immunohistochemistry Biocare’s Decloaker and 21 
Reveal Buffer (Biocare, Pacheco, CA) was used for antigen retrieval, and sections were 22 
treated with monoclonal mouse anti- desmin antibodies (Dako, Santa Clara, CA, 23 
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catalogue #M0760; 1:100 dilution, 30 minutes) For CD18 immunohistochemistry 1 
Carezyme I: Trypsin Kit (Biocare, Pacheco, CA) was used for antigen retrieval, then 2 
endogenous peroxidase activity was blocked with 3% H2O2 and monoclonal mouse anti-3 
feline CD18 antibody was applied (clone Fe3.9f2, Peter Moore, University of California-4 
Davis, Davis, CA; 1:10 dilution, 30 minutes,).6,8 Diaminobenzidine tetrahydrochloride 5 
was utilized as chromogen with hematoxylin counterstain. .  6 
For transmission electron microscopy, formalin-fixed samples of myocardium 7 
were washed in 0.1M sodium phosphate buffer, post-fixed in buffered 2% osmium 8 
tetroxide for 60 minutes, washed in water, and dehydrated in a graded ethanol series 9 
with final dehydration in propylene oxide. Samples then were embedded in Embed 812 10 
and semi-thin (1000nm) and thin sections (100nm) were prepared on a Leica EM UC7 11 
ultra-microtome and stained with UranyLess stain (Electron Microscopy Sciences, 12 
Hatfield, PA) followed by Reynolds lead citrate to increase the contrast. Sections were 13 
imaged in a Zeiss Libra 200MC operating at 200kV. 14 
The most striking histologic feature was expansion of approximately 80% of the 15 
myocardial interstitium by many cells with up to 20 nuclei and abundant pale 16 
eosinophilic cytoplasm distended by regularly shaped clear acicular spaces (Figures 1 17 
and 2). Similar cells, often multinucleated, were also identified within the interstitium of 18 
the skeletal muscle, although in lower numbers. These cells were immunoreactive for 19 
CD18 (Figure 3) and did not label with desmin, indicating a leukocytic origin. Given their 20 
multinucleation and similarity to Kupffer cells and pulmonary alveolar macropahges, 21 
they were interpreted as histiocytes. Additionally, myocardiocytes were variably sized 22 
(up to three-fold variation) and contained perinuclear brown pigment granules 23 
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(lipofuscin). Kupffer cells, (Figure 4) and pulmonary alveolar macrophages also 1 
contained similar clear, acicular spaces. Kupffer cells also contained abundant brown 2 
granular pigment, which stained blue with Prussian blue (data not shown) and was 3 
interpreted as hemosiderin. Notably, there was no evidence of these acicular spaces 4 
within macrophages in the intestinal lamina propria.  5 
Ultrastructurally, the spaces in myocardial macrophages were polygonal, 6 
electron-lucent, and lined by lipid membranes (Figures 5 and 6), consistent with an 7 
autophagosome. Other histologic findings included regionally extensive acute hepatic 8 
necrosis and chronic tubulointerstitial nephritis with chronic infarcts. Staining of multiple 9 
tissues with Ziehl-Neelsen and Fite-Faraco acid fast stains did not demonstrate acid-10 
fast bacteria. Although considered a significant contributor to clinical decline, a definitive 11 
cause of the hepatic necrosis was not identified. 12 
Given the historical treatment with clofazimine and the histologic and 13 
ultrastructural appearance of the crystalline spaces in macrophages, a diagnosis of 14 
clofazimine storage was made. Clofazimine crystals are soluble in organic solvents and 15 
alcohols and are therefore lost during routine tissue processing for histology and 16 
ultrastructural study, leaving only clear acicular spaces.25 In order to see crystals 17 
histologically, frozen sections must be examined. Frozen samples were not collected in 18 
this case.  19 
To our knowledge, this is the first report of clofazimine accumulation within the 20 
heart of a cat. Cardiotoxicity resulting in arrhythmias has previously been reported in 21 
humans treated with clofazimine for prolonged periods 7,10 and cardiac accumulation of 22 
clofazimine has been demonstrated in humans18 and rats.17 However, those studies did 23 
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not include histologic evaluation for comparison to this case. In mice and humans with 1 
many forms of chronic heart disease, the number of macrophages within the myocardial 2 
interstitium increases.12 Cats with hypertrophic cardiomyopathy have recently been 3 
shown to have increased numbers of macrophages within the myocardial interstitium.15 4 
Although lacking the classical finding of myocardial disarray, the variably-sized 5 
myocardiocytes in this cat, the subjective cardiomegaly with ventricular thickening, and 6 
increased cardiac weight (0.78% of body weight) are suggestive of, though not 7 
diagnostic for, hypertrophic cardiomyopathy. Alternatively, the increased heart weight 8 
may have been the result of infiltration of the myocardium by clofazimine-laden 9 
macrophages. A similar phenomenon of myocardial histiocytosis has also been 10 
demonstrated in humans and mice with chronic kidney disease5 but not, to our 11 
knowledge, in cats. The accumulation of clofazimine crystals within Kupffer cells2 and 12 
pulmonary alveolar macrophages14,21,23 has been previously documented in 13 
experimental and human literature and closely mirrors this case. Interestingly in this 14 
case, and in contrast to humans24,26 and experimental models2, macrophages in the 15 
intestinal lamina propria did not contain clofazimine crystals. The accumulation of 16 
crystal-laden macrophages within the skeletal muscle intersititum, to the authors’ 17 
knowledge has not been previously reported and may suggest an unusual distribution of 18 
clofazimine crystal storage in cats. 19 
Although clofazimine is a mainstay of treatment of mycobacteriosis in cats,16,22 20 
adverse effects rarely have been reported. Previously reported adverse effects are 21 
limited to gastrointestinal upset and photosensitization, both of which typically resolve 22 
following cessation of the medication. This report demonstrates clofazimine crystal 23 
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storage within myocardial and skeletal muscle interstitial macrophages, Kupffer cells, 1 
and pulmonary alveolar macrophages. Myocardial accumulation of clofazimine in this 2 
case could represent an adverse effect of clofazimine, or could potentially a be 3 
consequence of underlying cardiac pathological changes. In this case, the multiple 4 
adverse effects associated with administration of other medications may reflect an 5 
individual or species-specific sensitivity to various medications. Unfortunately, the role 6 
of clofazimine in the clinical decline in this case is not determined.  7 
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Figure Legend 23 
Figures 1-4. Clofazimine storage, cat. Figure 1. Myocardium. Diffusely, the interstitium 24 
is expanded by cells (macrophages) with abundant pale eosinophilic cytoplasm and 25 
intracytoplasmic acicular spaces. (HE) Figure 2. Myocardium. Higher magnification of 26 
Figure 1. The cells within the interstitium have up to 20 nuclei and their cytoplasm is 27 
distended by abundant acicular spaces (arrows). (HE) Figure 3. Myocardium. Cells 28 
within the interstitial spaces are immunoreactive to CD18, indicating a leukocytic origin. 29 
Immunohistochemistry for CD18. Figure 4. Liver. Fixed macrophages including Kupffer 30 
cells contain intracytoplasmic crystalline spaces and abundant granular golden-brown 31 
pigment (hemosiderin). (HE)  32 
Figures 5 and 6. Clofazimine storage, myocardium, cat Transmission electron 33 
microscopy. Figure 5. Ultrastructurally, macrophages contain intracytoplasmic 34 
membrane-bound acicular spaces. Figure 6. Higher magnification of Figure 5. An 35 
acicular space (asterisk) is bound by a lipid bilayer (arrows). 36 
